CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suzuki, T.
Right arrow Articles by Savarese, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, T.
Right arrow Articles by Savarese, J. J.
Canadian Journal of Anesthesia 50:879-885 (2003)
© Canadian Anesthesiologists' Society, 2003

General Anesthesia

Edrophonium effectively antagonizes neuromuscular block at the laryngeal adductors induced by rapacuronium, rocuronium and cisatracurium, but not mivacurium

[L’édrophonium antagonise efficacement le blocage neuromusculaire des adducteurs laryngés induit par le rapacuronium, le rocuronium et le cisatracurium, mais non par le mivacurium]

Takahiro Suzuki, MD PhD, Cynthia A. Lien, MD, Matthew R. Belmont, MD, Joseph Tjan, MD and John J. Savarese, MD

From the Department of Anesthesiology, New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, New York, USA.

Address correspondence to: Dr. Takahiro Suzuki, 3-24-3, Asagaya-Kita, Suginami-Ku, Tokyo 166-0001, Japan. Phone: +81-3-3336-0428; Fax: +81-3-3336-0428; E-mail: suzukit{at}cd5.so-net.ne.jp

Purpose: To examine the efficacy of antagonism of rapacuronium-, mivacurium-, rocuronium- and cisatracurium-induced neuromuscular block at the laryngeal adductors (LA).

Methods: One hundred four patients were randomly assigned to one of eight study groups. They either received rapacuronium 1.5 mg•kg-1, mivacurium 0.25 mg•kg-1, rocuronium 0.9 mg•kg-1 or cisatracurium 0.15 mg•kg-1. Patients in each treatment group either received edrophonium (0.5 mg•kg-1) at 10% recovery of the first twitch (T1) of train-of-four (TOF) at the LA or were allowed to recover spontaneously from neuromuscular block. The effect of antagonism on speed of recovery of neuromuscular function at the LA was evaluated.

Results: The time to recovery to a TOF ratio of 0.9 at the LA, when compared to the spontaneous recovery group, was significantly shortened by the administration of edrophonium in patients receiving rapacuronium [19.2 ± 7.8 vs 26.2 ± 4.9 (mean ± SD) min], rocuronium (24.7 ± 14.3 vs 44.4 ± 13.0 min) and cisatracurium (24.2 ± 5.7 vs 35.1 ± 7.6 min). Edrophonium administration did not shorten complete recovery from mivacurium-induced block (15.7 ± 8.0 vs 17.6 ± 6.1 min).

Conclusion: Recovery from rapacuronium-, rocuronium- or cisatracurium- induced neuromuscular block to a TOF ratio of 0.9 as measured at the LA was shortened by the administration of edrophonium, when compared to spontaneous recovery.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
B. F. Vanacker, K. M. Vermeyen, M. M. R. F. Struys, H. Rietbergen, E. Vandermeersch, V. Saldien, A. F. Kalmar, and M. E. Prins
Reversal of Rocuronium-Induced Neuromuscular Block with the Novel Drug Sugammadex Is Equally Effective Under Maintenance Anesthesia with Propofol or Sevoflurane
Anesth. Analg., March 1, 2007; 104(3): 563 - 568.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Canadian Anesthesiologists' Society.